Please try another search
Vifor Pharma, Inc., a biopharmaceutical company, develops and commercializes late-stage medicines in the iron deficiency, nephrology, and cardio-renal therapeutic areas. The company develops VELTASSA, a potassium binder for the treatment of hyperkalemia. The company was incorporated in 2007 and is headquartered in Redwood City, California. The company was formerly known as Relypsa, Inc. and changed its name to Vifor Pharma, Inc. in February 2021. As of August 31, 2016, Vifor Pharma, Inc. operates as a subsidiary of Vifor Pharma Ltd.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review